Epidemiology of brain metastases and leptomeningeal disease

N Lamba, PY Wen, AA Aizer - Neuro-oncology, 2021 - academic.oup.com
Brain metastases affect a significant percentage of patients with advanced extracranial
malignancies. Yet, the incidence of brain metastases remains poorly described, largely due …

Multiplicity of cerebrospinal fluid functions: New challenges in health and disease

CE Johanson, JA Duncan, PM Klinge, T Brinker… - Cerebrospinal fluid …, 2008 - Springer
This review integrates eight aspects of cerebrospinal fluid (CSF) circulatory dynamics:
formation rate, pressure, flow, volume, turnover rate, composition, recycling and …

Exosome Delivered Anticancer Drugs Across the Blood-Brain Barrier for Brain Cancer Therapy in Danio Rerio

T Yang, P Martin, B Fogarty, A Brown… - Pharmaceutical …, 2015 - Springer
Purpose The blood–brain barrier (BBB) essentially restricts therapeutic drugs from entering
into the brain. This study tests the hypothesis that brain endothelial cell derived exosomes …

Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study

DN Cagney, AM Martin, PJ Catalano, AJ Redig… - Neuro …, 2017 - academic.oup.com
Background Brain metastases are associated with significant morbidity and mortality.
Population-level data describing the incidence and prognosis of patients with brain …

Heterogeneous blood–tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer

PR Lockman, RK Mittapalli, KS Taskar, V Rudraraju… - Clinical cancer …, 2010 - AACR
Purpose: Brain metastases of breast cancer appear to be increasing in incidence, confer
significant morbidity, and threaten to compromise gains made in systemic chemotherapy …

The biology of brain metastases—translation to new therapies

AF Eichler, E Chung, DP Kodack, JS Loeffler… - Nature reviews Clinical …, 2011 - nature.com
Brain metastases are a serious obstacle in the treatment of patients with solid tumors and
contribute to the morbidity and mortality of these cancers. It is speculated that the frequency …

Engaging neuroscience to advance translational research in brain barrier biology

EA Neuwelt, B Bauer, C Fahlke, G Fricker… - Nature Reviews …, 2011 - nature.com
The delivery of many potentially therapeutic and diagnostic compounds to specific areas of
the brain is restricted by brain barriers, of which the most well known are the blood–brain …

Cyclic RGD-linked polymeric micelles for targeted delivery of platinum anticancer drugs to glioblastoma through the blood–brain tumor barrier

Y Miura, T Takenaka, K Toh, S Wu, H Nishihara… - ACS …, 2013 - ACS Publications
Ligand-mediated drug delivery systems have enormous potential for improving the efficacy
of cancer treatment. In particular, Arg-Gly-Asp peptides are promising ligand molecules for …

Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions

AA Aizer, N Lamba, MS Ahluwalia, K Aldape… - Neuro …, 2022 - academic.oup.com
Brain metastases occur commonly in patients with advanced solid malignancies. Yet, less is
known about brain metastases than cancer-related entities of similar incidence. Advances in …

A predictive microfluidic model of human glioblastoma to assess trafficking of blood–brain barrier-penetrant nanoparticles

JP Straehla, C Hajal, HC Safford… - Proceedings of the …, 2022 - National Acad Sciences
The blood–brain barrier represents a significant challenge for the treatment of high-grade
gliomas, and our understanding of drug transport across this critical biointerface remains …